1. Home
  2. SIDU vs TNXP Comparison

SIDU vs TNXP Comparison

Compare SIDU & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sidus Space Inc.

SIDU

Sidus Space Inc.

HOLD

Current Price

$2.18

Market Cap

151.0M

ML Signal

HOLD

Logo Tonix Pharmaceuticals Holding Corp.

TNXP

Tonix Pharmaceuticals Holding Corp.

HOLD

Current Price

$11.98

Market Cap

172.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SIDU
TNXP
Founded
2012
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
151.0M
172.7M
IPO Year
2021
2008

Fundamental Metrics

Financial Performance
Metric
SIDU
TNXP
Price
$2.18
$11.98
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
6.6M
375.9K
Earning Date
05-14-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
84.42
91.75
EPS
N/A
N/A
Revenue
$4,672,646.00
$13,107,000.00
Revenue This Year
N/A
$566.15
Revenue Next Year
$100.00
$36.04
P/E Ratio
N/A
N/A
Revenue Growth
N/A
29.85
52 Week Low
$0.63
$12.70
52 Week High
$5.39
$69.65

Technical Indicators

Market Signals
Indicator
SIDU
TNXP
Relative Strength Index (RSI) 46.37 35.47
Support Level $0.89 N/A
Resistance Level $2.19 $20.36
Average True Range (ATR) 0.31 1.06
MACD 0.03 -0.13
Stochastic Oscillator 16.81 7.92

Price Performance

Historical Comparison
SIDU
TNXP

About SIDU Sidus Space Inc.

Sidus Space Inc is a Space and Defense as-a-Service company focused on providing complex space hardware, satellite/spacecraft design, manufacture, launch, and data solutions for both government and commercial in-space missions for all destinations through the solar system. This includes a Space-based infrastructure of multi-mission satellites with hyperspectral, multi-spectral, and other sensors to provide monitoring services and solutions to multiple sectors and industries. The company supports Commercial Space, Aerospace, Defense, Underwater Marine, and other commercial and government customers.

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a fully-integrated biopharmaceutical company commercializing and developing therapies for central nervous system (CNS) disorders, immunology, infectious diseases, and rare diseases. Its portfolio consists of commercial, development and discovery-stage programs, TONMYA, an approved treatment for fibromyalgia, as well as marketed acute migraine products Zembrace SymTouch and Tosymra. The company is conducting clinical trials to evaluate TONMYA for additional indications such as depressive disorder and acute stress disorder. It is also advancing a pipeline of immunology programs, including monoclonal antibody TNX-4800 for Lyme disease prophylaxis and TNX-1500, a third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection.

Share on Social Networks: